Robin Richards Donohoe

Provides integrated digital marketing solutions

Draper Richards invests in early-stage technology companies, typically in a company's first round of financing. The majority of their portfolio is in information technology and telecommunications companies. The firm prefers companies with a team who is extremely motivated to do whatever it takes to make a success of the company and a product or service which possesses some differentiating feature that can lead to the creation of a profitable company. They have a distinct bias toward business models with high gross margins. Companies must be those that can defend its position in its market once established.

Provides interactive exhibits in the area of science

Functions as a College/University

Promotes social good and helps less fortunate people

Functions as a College/University

The Bluefield Project to Cure Frontotemporal Dementia is a non-profit organization focused on accelerating the development of treatments and finding a cure for frontotemporal dementia (FTD), a fatal early-onset brain disease primarily affecting people under 60. The private company is based in San Francisco, CA. The organization targets FTD caused by mutations in the progranulin gene (GRN), funding basic, translational, and clinical research through a consortium of academic institutions and fostering collaboration between scientists and clinicians. Key therapeutic priorities include increasing progranulin levels, reducing neuroinflammation, and improving lysosomal function and protein homeostasis. Bluefield also supports biomarker studies and patient registries to aid research and clinical trial enrollment. The company was founded by Richards Donohoe Robin.